Findings from a discontinued clinical trial of favipiravir in high-risk patients with early-onset COVID-19.
Iwata S, Kobayashi O, Kurashima K, Doi Y, Kunishima H, Shinkai M, Tsushima K, Yamato M, Kano A, Hibino M, Yamatake T, Sakurai T, Ogura T.
Iwata S, et al. Among authors: kano a.
J Infect Chemother. 2024 Mar;30(3):219-227. doi: 10.1016/j.jiac.2023.10.010. Epub 2023 Oct 12.
J Infect Chemother. 2024.
PMID: 37832822
Free article.
Clinical Trial.